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Studies were performed to explore the effect on normal lymphocyte function of serum derived from
patients with alcohol-induced liver injury and healthy controls. Weexamined the effect ofsuch serum on the
generation of both spontaneous and Concanavalin A (Con A)-induced lymphocyte cytotoxicity for Chang
target cells. Normal lymphocytes, when incubated in the presence of 5% serum from patients with alcoholic
liver disease, showed a marked (20.75 i 5.1% mean i SEM) reduction in the capacity to generate sponta-
neously cytotoxic cells compared to 5% control serum (3.2 i 1.91%) (p < 0.001). Similar results were found
in studies of Con A-stimulated cytotoxicity (36 ± 7.2% vs. 5 * 2.3%; p < 0.001). Fractionation of serum by
gel chromatography demonstrated the presence ofinhibitory activity ofvarious molecularweights, although
a major peak of inhibitory activity (approximately 270,000 daltons) was identified in severe alcoholic
hepatitis. Thus, this study demonstrates the presence of serum inhibitors in alcoholic liver disease which
influence normal lymphocyte function.
INTRODUCTION
Alcoholic liver disease and, in particular, acute alcoholic hepatitis have been
associated with a number of immunologic abnormalities. In vivo studies of delayed
hypersensitivity skin testing have shown depressed thymus-derived or T-lymphocyte
function in patients with alcohol-induced liver injury [1,2]. In such patients, both a
peripheral T-lymphopenia and marked accumulation of T-cells at the site of liver
injury have been described [3,4] and in vitro studies of lymphocyte activity have
demonstrated depressed lymphocyte responsiveness to antigens and mitogens [5].
Furthermore, lymphocyte reactivity to liver tissue antigens and alcoholic hyalin have
been demonstrated in some individuals [5-7]. More important, mononuclear cells
from patients with alcoholic hepatitis but not inactive Laennec's cirrhosis exhibit
cytotoxicity to autologous and heterologous cell lines, suggesting prior in vivo
lymphocyte activation [8-10]. It is uncertain, however, whether these immunologic
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abnormalities are primary and of pathogenetic significance or represent secondary
and non-specific changes due to the disease process or a direct alcohol effect on
immunologic responsiveness.
The importance of external modulating factors on in vitro lymphocyte function
has only recently been appreciated. In patients with alcoholic liver disease, serum
factors have been shown to play an important role in certain aspects ofcell function.
For example, DeMeo and Andersen [I1] studied neutrophil chemotaxis in patients
with alcoholic liver disease and found that the cirrhotic patients had marked
impairment of chemotaxis compared to normal controls when neutrophils were
incubated with autologous but not homologous normal serum. Ofparticular interest
were investigations in which normal leukocytes exhibited defective chemotaxis inthe
presence of alcoholic liver disease serum but not in the presence of normal serum.
Thus, this study represents an example of an external modulating serumfactor(s) on
a particular cell function in patients with alcohol-induced liver injury.
In the present investigation, we examined the effect of serum obtained from
patients in various stages ofacute alcoholic liverinjury on the generation ofcytotoxic
lymphocytes. Our results indicated that there are potent serum inhibitors which
depress the generation of cytotoxic lymphocytes derived from normal individuals.
MATERIALS AND METHODS
Patients
Fifteen patients with alcohol-related liver disease were investigated. Twelve ofthe
15 underwent liver biopsy; 7 demonstrated morphologic features consistent with
alcoholic hepatitis [12], 4 with Laennec's cirrhosis, and 1 with fatty liver. Ten
milliliters of venous blood was collected from each patient and the separated serum
stored at -70°C for subsequent studies. All patients were hospitalized and studied
between 3 days and 2 weeks following admission. This protocol has been approved by
the Human Studies Committee at the Massachusetts General Hospital.
Preparation ofLymphocytes
Mononuclear cells obtained from normal individuals were prepared from 40 to
50 ml offresh heparinized venous blood bydilutionwith an equal volume ofisotonic
saline and centrifugation through a Ficoll/Hypaque sedimentation gradient 400 x g
for 35 min; the mononuclear cell band at the saline-Ficoll/Hypaque interface was
removed. Cells were washed three times (400 x g for 10 min) in RPMI 1640 medium
(Microbiological Associates, Bethesda, MD) enriched with 10% heat-inactivated fetal
calf serum, 20 mM glutamine, penicillin (1000 units/ml) and streptomycin (100
,ug/ml) (complete medium). Cells were resuspended in complete medium and
adjusted to a concentration of 1 x 106 cells/ml. Under these conditions cell viability
was > 95% by trypan blue exclusion.
Preparation of Target Cells
Chang cells (Microbiological Associates) were continuously cultivated in our
laboratory and a single cell suspension was harvested by brief treatment with trypsin
(5 min). Cells were washed three times in RPMI medium, resuspended in 5 ml of
complete medium, and incubated with 300 /ACi of 51Cr (New England Nuclear,
Boston, MA) for 30 min at 37°C. Radiolabeled Chang cells were washed X3 with
10 ml of complete medium, counted, and rechecked for viability with trypan blue.
The final concentration of target cells was adjusted to 1 x 104 cells/ml.
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Cytotoxicity Studies
In both the spontaneous and Con A-induced lymphocyte cytotoxicity studies, done
in triplicate, 2 ml of complete medium containing 1 x 106 mononuclear cells/ml were
added to 1 x 104 labeled Chang cells in 1 ml of complete medium to yield a
lymphocyte to target cell ratio of 200:1. In spontaneous lymphocyte cytotoxicity
studies 2 x 106 lymphocytes were incubated in complete RPMI medium for 18 hours
with 1 x 104 Chang cells on a rocker platform (6 cycles/min at 37°C in a95% air and
5% CO2 atmosphere). At the end of this incubation period, cell suspensions were
transferred from 35 x 25 mm plastic petri dishes to small test tubes and centrifuged at
450 x g for 15 min. The supernatant was carefully decanted into counting tubes and
counted in a three-channel Packard gamma counter (Packard Instrument Co., Inc.,
LaGrange, IL). The mean counts per 5 min release from 1 x 104 Chang cells and
standard error of the mean were calculated. Cytotoxicity was measured by 5'Cr
release into the medium after incubation with mononuclear cells. Percent lymphocyte
cytotoxicity was calculated from the following formula:
% cytotoxicity = XT- SR x 100% TRC - SR
where X = mean cpm measured in tubes containing 5'Cr-labeled Chang cells and
lymphocytes
SR = cpm in tube containing 5'Cr-labeled Chang cells without lymphocytes
(spontaneous release)
TRC = total releasable counts of 1 x 104 51Cr-labeled Chang cells by freeze-
thawing three times
Concanavalin A (Con A) was a thrice-crystallized preparation obtained from
Miles-Yeda (Elkhard, IN). For Con A-stimulated cytotoxicity studies, mononuclear
cells prepared in an identical fashion were incubated at a concentration of 1 x 106
cells/ml in complete medium (total volume 2 ml) with 10Mg/ml Con A for 72 hr in a
5% Co2 incubator at 370C. At the end ofthis incubation period, cell suspensions were
added to 1 x 104 51Cr-Chang cells and incubated for 6 hr as described above and the
percent cytotoxicity determined.
Inhibition ofLymphocyte Cytotoxicity by Serum
Serum from patients with alcohol-related liver injury and from normal control
individuals was heat-inactivated at 560C for 30 min. Such serum at a concentration
of 5% was added to duplicate cultures at the beginning of the 18 hr period in the
spontaneous lymphocyte cytotoxicity experiments and the 72 hr incubation in the
Con A-stimulated studies. Serum from normals was always present in parallel
experiments as a control. To assure that the added serum was not cytotoxic toward
normal mononuclear cells, we evaluated cell viability at 12, 24, 48, and 72 hrs by
trypan blue exclusion. There was no significant difference in cell viability between
cultures with or without serum addition. To assure that serum from normals and
patients with alcoholic liver disease did not effect 5'Cr release from Chang cells,
parallel experiments were performed with 5% serum added to 1 x 104 51Cr-labeled
Chang cells during the 18 and 6 hr incubations. There was no increased 5'Cr with
such addition compared to spontaneous 51Cr release from Chang cells cultured under
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identical conditions. Percent inhibition of both spontaneous and Con A-stimulated
cytotoxicity was calculated according to the following formula.
% inhibition of = 1 % cytotoxicity with serum addition x 100
cytotoxicity % cytotoxicity without serum addition
Partial Characterization ofSerum Inhibitory Factors
In order to characterize serum inhibitory activity and to determine the approxi-
mate molecular weight of such inhibitor(s), we performed cytotoxicity studies with
serum obtained from normal and alcoholic liver disease patients and fractionated by
column chromatography. A 2.5 x 30 cm column was packed at 12 cm H20 pressure
with Sephadex G-200 (Pharmacia) dissolved in phosphate buffered saline (PBS)
(pH 7.2) containing 0.01% sodium azide and had a flow rate of 12 ml/hr. This
column was calibrated with blue dextran, bovine hemoglobulin, human 1251-IgG and
3H-glucose. Two ml fractions were collected. A similar column was prepared with
Sepharose 4B but was packed at 30 cm of H20 pressure with a measured bed volume
of 96 ml and had a flow rate of 24 ml/hr. This column was calibrated with blue
dextran, horse spleen ferritin, and '251-IgG.
Consecutive fractions were pooled to form 10 ml aliquots, concentrated 5X bythe
use of collodion bags (Arthur Thomas), dialyzed against PBS to remove sodium
azide, lyophilized, reconstituted in PBS to a volume of 2 ml and filtered through a
0.45 ji Millipore filter. Fractions collected and prepared in this way were added in
0.2 ml aliquots (in triplicate) to lymphocyte suspensions at the time of Con A
stimulation and were present for the entire 72 hr incubation period. Thecytotoxicity
assay was subsequently performed as previously described.
RESULTS
Characteristics ofthe Cytotoxicity Assay
Preliminary 51Cr labeling experiments demonstrated that Chang cells yielded
1 x 103 to 2 x 103 cpm/ 104 cells. When labeling was less than 1 x 103 cpm/ 104 cells,
the experiment was discarded. Spontaneous release was usually less than 15% ofthe
total releasable counts as determined by freeze-thawing the 51Cr Chang cells. The
releasable counts averaged 80 i 5.6% of the total cpm/ 104 cells. Studies on lympho-
cytes obtained from 15 normal control individuals yielded values of 26 ± 5.2
(mean ± SEM) % for spontaneous lymphocyte cytotoxicity and 38 ± 7.6 for Con A-
stimulated cytotoxicity.
Inhibition ofSpontaneous and Con A-Induced Lymphocyte Cytotoxicity
by Serumfrom Patients with Alcoholic Liver Disease
Serum obtained from patients with alcohol-related liver disease had a profound
effect on the generation of cytotoxic lymphocytes obtained from normal control
individuals as shown in Figs. 1 and 2. As depicted in Fig. 1, there was a substantial
difference in the inhibition of spontaneous cytotoxic lymphocytes when cells were
incubated in the presence of5% normal serum compared to 5% alcoholic liverdisease
serum (3.2 ± 1.9 vs. 20.75 ± 5.1%; p < 0.001). Similarly, in Con A-stimulated experi-
ments in which maximum cytotoxicity is generated, alcoholic liver disease serum
inhibited cytotoxicity by 36 ± 7.2% as compared to 5 ± 2.3% inhibition by normal
serum (p < 0.001).
We compared the results obtained on serum inhibition ofcytotoxicityexhibited in
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FIG. 1. Effect of serum obtained from alcoholic
liver disease patients and normal controls on sponta-
neous cytotoxicity exhibited by normal lymphocytes
against 51Cr-labeled Chang target cells.
k 70
N..
'--) 50
R 3C
IC
the spontaneous assay to that observed in the Con A-stimulated experiments as
shown in Table 1. (Clinical and laboratoryfeatures ofthese patients are presented for
reference in Table 2.) There was no relationship between the magnitude ofdepressed
lymphocyte reactivity in the two assays. In fact, we observed in some patients a
dissociation between the inhibitory effect of serum in the spontaneous assay
compared to the Con A-stimulated studies (e.g., Patients 1 and 5). However, the
greatest degree of serum inhibitory activity was observed in patients with severe
alcoholic hepatitis.
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FIG. 2. Inhibition of concanavalin A-stimulated
lymphocyte cytotoxicity against 51Cr-labeled Chang cells
by serum obtained from patients with alcoholic liver
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TABLE I
Representative Comparisons Between Inhibition of Spontaneous and Con A-stimulated Lymphocyte Cytotoxicity
Patient % Inhibition spontaneous* % Inhibition Con A-induced**
No. lymphocyte cytotoxicity lymphocyte cytotoxicity
1 6 56
2 27 42
3 17 71
4 6 22
5 30 3
6 16 0
7 14 35
8 5 32
9 62 69
10 36 25
11 33 45
12 0 30
13 7 33
14 25 -
15 21
* Percent spontaneous lymphocyte cytotoxicity as measured on 15 controls was 26 i 5.2%.
** Percent Con A-induced lymphocyte cytotoxicity as measured on 32 control subjects was 38 ± 7.6% (see Materials
and Methods).
Partial Characterization of Serum Inhibitors
Figure 3 depicts a representative elution profile of serum inhibitory activity on
Sephadex G-200 columns in two patients with severe alcoholic hepatitis (III and IV)
compared to a patient with active Laennec's cirrhosis (II) and a normal control (I).
All three patients had previously deternrined inhibitory activity when tested at a 5%
serum concentration in the Con A-stimulated cytotoxicity assay. In the alcoholic
TABLE 2
Clinical and Laboratory Data on 8 Patients with Alcoholic Liver Disease
Total
Patient Age/ SGOT A/G* PT**P/C Bili Alk Phos
No. Sex (lU/ml) (gm%) (sec) (mg%0) (BU) Liver Bx
I 54M 87 2.1/5.2 16.0/11.6 14.2 8.6 Alcoholic hepatitis
2 43F 49 3.0/4.6 14.1/11.7 8.2 9.4 Alcholic hepatitis
3 54F 106 2.9/3.2 12.1/11.6 2.4 11.6 Alcoholic hepatitis
4 18M 81 3.0/4.9 15.0/11.1 17.0 6.4 Alcoholic hepatitis
5 47F 31 3.1/3.6 13.0/11.9 0.8 6.8 Laennec's cirrhosis
6 28F 42 4.2/3.9 10.3/10.7 0.3 9.8 Fatty infiltration
7 38M 306 4.8/3.6 10.1/11.1 2.2 9.7 -
8 60M 53 2.2/3.9 13.8/11.2 1.9 7.8 "Active" Laennec's cirrhosis
9 42M 86 2.1/5.4 14.5/12.0 12.0 8.6 Alcoholic hepatitis
10 37M 42 3.1/3.9 12.6/11.7 1.1 5.4 -
I1 55M 126 2.8/4.1 13.6/11.4 5.9 6.1 Alcoholic hepatitis
12 47F 56 3.7/3.9 12.0/11.9 1.4 3.9 Laennec's cirrhosis
13 62M 41 3.5/3.2 12.1/11.7 0.9 4.9 Laennec's cirrhosis
14 51F 129 2.8/4.6 15.1/11.9 9.6 8.2 Alcoholic hepatitis
15 29F 92 3.0/4.5 15.6/12.0 4.0 10.0 -
*A/G = albumin/globulin; nl values for albumin > 3.5 gm%, globulin < 3.0 gm%
**PT = prothrombin time; P/C = patient/control
Normal values for total bilirubin < 0.8% mg%/ and alkaline phosphatase < 4.2 Bodansky Units (BU)LYMPHOCYTE INHIBITION IN ALCOHOLIC LIVER DISEASE
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FIG. 3. Elution profile of serum inhibitory activity
obtained after fractionation over a Sephadex G-200
column. I represents a control, II active Laennec's
cirrhosis, III and IV severe alcoholic hepatitis (see
Material and Methods.)
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hepatitis patients there was a peak of serum inhibitory activity corresponding to a
molecular weight of approximately 270,000 daltons when further analyzed by
Sepharose 4B chromatography (data not shown). However, lower levels ofinhibitory
activity were observed in lower molecular weight fractions on Sephadex G200 as
exemplified by patient II with active Laennec's cirrhosis.
DISCUSSION
In patients with alcohol-related liver injury we demonstrated the existence of
serum factor(s) which inhibit the generation of cytotoxic activity in lymphocytes
obtained from normal controls. What are the biological properties and significance
of these inhibitory substances? In the first place, the biological potency varies from
patient to patient as shown in some studies (Fig. 3, patient III) in which peak serum
inhibitory activity almost completely abolished the Con A-generated response, while
in others (Figs. 1 and 2) less inhibitory activity was found. These serum substances do
not appear to be cytotoxic toward normal lymphocytes, as shown by trypan blue
exclusion studies, or to the target cells, as illustrated by the lack of enhanced 5'Cr
release in the absence of effector cells. The mechanism(s) of this effect on normal
lymphocyte reactivity, however, is unknown.
Although we observed the greatest degree of serum inhibition of lymphocyte
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patients in various stages of alcohol-induced injury would be needed before an
association between such inhibitors and disease severity could be drawn. Our studies
indicate that serum from such patients contains inhibitory activity over a broad
molecular weight range. A major peak of inhibitory activity, however, was identified
in the range of 270,000 daltons in the 5 patients studied thus far with severe alcholic
hepatitis.
Recent studies have demonstrated that Con A-stimulated lymphocyte cytotoxicity
toward Chang cells is probably mediated by T-lymphocytes whereas spontaneous
cytotoxicity directed against these same target cells is a property of a non-adherent,
surface immunoglobulin-negative, Fc receptor-positive cell population [13-14].
Based on the dissociation noted in many patients between the degree of inhibition in
the spontaneous and the Con A-induced cytotoxicity experiments, we are tempted to
speculate that these serum inhibitors may influence lymphocyte subpopulations to
variable degrees; however, lymphocyte separation experiments are necessary to
explore this possibility.
In this study we chose to focus on the effects of serum inhibitory factors on normal
lymphocyte reactivity, for patients with liver disease may have intrinsic as well as
extrinsic defects in lymphocyte function. Indeed, three types of serum inhibitors
(extrinsic factors) which influence various aspects of lymphocyte reactivity have been
described. Several studies have shown that in pwtients with a variety ofliver diseases
(alcoholic hepatitis, viral hepatitis, primary biliary cirrhosis, halothane hepatitis, and
extrahepatic biliary obstruction) there are serum inhibitors which depress phyto-
hemagglutinin (PHA) stimulated blast transformation in lymphocytes obtained both
from patients and normal individuals [15-20]. The properties of these inhibitors are
unknown.
More recently, Chisari et al. have described a "regulatory" low density lipoprotein
which inhibits T-lymphocyte binding to sheep red blood cells (SRBC rosette
formation) in patients with acute viral hepatitis. This substance has been named
rosette inhibitory factor or RIF [21,22]. Rosette inhibitory factor is biologically
active at extremely low concentrations and is found in approximately 50 percent of
patients with type A or B hepatitis during the active course of illness. Apparently RIF
has unusual specificity for viral hepatitis and has not been detected in other viral
diseases or in a variety of acute and chronic liver diseases of other etiologies. More
important, the persistence of this factor in the blood following acute hepatitis has
been associated with unresolved hepatitis and chronic active hepatitis. No correlation
has been found, however, between RIF and the inhibitory factor(s), mentioned
above, which inhibit the DNA synthetic response to PHA [22].
A third serum factor has been described in patients with acute and chronic active
hepatitis which inhibits spontaneous and Con A-induced lymphocyte cytotoxicity
[23]. These factor(s), like RIF, disappear with clinical recovery [24]; however, the
biological properties differ from those of RIF in that the major peak of serum
inhibitory activity determined by gel chromatography occurs in the 160,000-180,000
dalton range in contrast to the large molecular weight of RIF [22]. The above data
suggest that there are multiple serum inhibitors of lymphocyte function in patients
with acute and chronic active hepatitis, some of which may be more specific for the
disease process than others.
We have shown, in addition, that in patients with alcoholic liver disease serum
inhibitors occur which influence the generation of cytotoxic lymphocytes. These
inhibitors were partially characterized and found to differ in molecular weight from
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those previously described in acute and chronic active hepatitis and primary biliary
cirrhosis [25]. Similar to the inhibitors observed by DeMeo et al. [11], the serum
factor(s) described here exert an inhibitory effect on normal cells. Finally, additional
studies are required to define further the physical properties of these inhibitors,
examine inhibitory effects of serum on lymphocyte subpopulations and other forms
of lymphocyte reactivity, determine whether the activity of these inhibitors varies
during the natural course of alcohol-induced liver injury, and explore the biological
significance of these potential regulatory substances.
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